Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vaccine research network awarded £1.2 million grant
The network has members in 93 countries.
The network supports livestock and zoonotic vaccine research.

The International Veterinary Vaccinology Network (IVVN), based at the Roslin Institute, has been awarded a £1.2 million grant from the Medical Research Council.

The network, which is made up of more than 1,900 scientists and industry partners from 93 countries around the world, aims to help develop improved vaccines for livestock and zoonotic diseases.

It is one of five global vaccine networks which provide a collaborative platform for researchers, particularly from low and middle income countries, to share knowledge and expertise.
 
The funding will allow IVVN to provide funding for collaboration between scientists, offer training opportunities, and engage the next generation of scientists.

Dr Timothy Connelley, network director of IVVN, said: “We are delighted to have been awarded funding to continue our activities to support veterinary vaccinologists across the world.

“With this funding, we will continue efforts to bring the human and veterinary vaccine research communities together, support scientific collaboration by providing pump-priming funding, provide training for early career researchers and expand our schools outreach programme to inspire the next generation of scientists.”

Dr Mark Palmer, director of international strategy at the Medical Research Council, said: “Investing in collaborations like these will better prepare us for future disease epidemics and to more effectively tackle the slow-moving pandemic of antimicrobial resistance.

“These global networks are integral to ensuring the UK harnesses the extraordinary potential of research and innovation to enrich and improve the lives of people living in the UK and around the world.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.